“Jams bleed; pharma pivot beckons.”
No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for TAPIFRUIT today. That isn't bearish, just inconclusive.
50-day SMA is below 200-day SMA (bearish long-term trend)
India-specific risk checks.
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
Valuations look stretched
Growth is soft or negative
Weak returns and margins
Adequate balance sheet
Data as of 16 Sept 2026, 9:48 pm